![](https://www.webhealthnetwork.com/img/webhealth-logo.png)
Fibrosarcoma - 88 Studies Found
Completed |
: Neoadjuvant Imatinib in Dermatofibrosarcoma Protuberans : Dermatofibrosarcoma Protuberans : 2005-10-20 : Drug: imatinib mesylate 400 mg orally twice a day for 10 - 14 days |
Completed |
: Imatinib in Dermatofibrosarcoma Protuberans (DFSP) : Dermatofibrosarcoma : 2005-07-20 : Drug: Imatinib (Glivec) |
Completed |
: Clinical Outcome of Pediatric Dermatofibrosarcoma Protuberans : Soft Tissue Neoplasms : 2005-09-12 |
Recruiting |
: Multi-Institutional Registry for Malignant Peripheral Nerve Sheath Tumors : Malignant Peripheral Nerve Sheath Tumors : 2017-04-13 |
Terminated |
: Imatinib Mesylate Treatment of Patients With Malignant Peripheral Nerve Sheath Tumors : Malignant Peripheral Nerve Sheath Tumors : 2007-01-25 : Drug: imatinib mesylate |
Recruiting |
: A Study of Pembrolizumab in Patients With Malignant Peripheral Nerve Sheath Tumor (MPNST), Not Eligible for Curative Surgery : Malignant Peripheral Nerve Sheath Tumour (MPNST) : 2016-02-04 : Drug: Pembrolizumab Other Name: Keytruda |
Recruiting |
: PLX3397 Plus Sirolimus in Unresectable Sarcoma and Malignant Peripheral Nerve Sheath Tumors :
: 2015-10-21 :
|
Active, not recruiting |
: SARC023: Ganetespib and Sirolimos in Patients With MPNST (Malignant Peripheral Nerve Sheath Tumors) :
: 2013-11-25 : |
Recruiting |
: Vaccine Therapy in Treating Patients With Malignant Peripheral Nerve Sheath Tumor That is Recurrent or Cannot Be Removed by Surgery :
|
Active, not recruiting |
: SARC016: Study of Everolimus With Bevacizumab to Treat Refractory Malignant Peripheral Nerve Sheath Tumors :
|